Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Sep / Research Roundup (2)
Microbiology & Immunology Microbiology and Immunology Oncology Technology and innovation

Research Roundup

The latest research in pathology and laboratory medicine

By Liv Gaskill 09/15/2021 Quick Read (pre 2022) 1 min read

Share

Oncotarget: Acquired
Though human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma is on the rise, palliative treatment is still the norm. However, researchers have developed a new droplet digital PCR-based assay to detect HPV16 circulating tumor DNA and found that long-term changes to HPV16 ctDNA can predict treatment response earlier than standard imaging (1).

Reservoir Cells
TCF1+ tumor-specific CD8+ T cells have been found in lung tumors throughout their development (2). Though most intratumoral T cells change with tumor progression, many tumor-specific CD8+ T cells found in tumor-draining lymph nodes were stable over time, regardless of changes within the tumor microenvironment.

Photo Finish
Using photoimmobilized proteins, researchers have developed an automated microarray diagnostic system for detecting SARS-CoV-2 protein-specific antibodies (3). The test yielded superior sensitivity to conventional chromatography and demonstrated its usefulness for rapid serodiagnosis and immune status assessment of viral infectious diseases.

Safety Assurance
Use of organs donated by people with HIV to recipients with HIV is increasing – and a new study provides some reassurance when it comes to resistance risk (4). The researchers found that, though HIV drug resistance mutations are common, resistance that could affect integrase strand transfer inhibitor-based regimens is rare.

Face-to-Face
A new machine learning facial analysis tool may detect risk of genetic syndromes in children with an average accuracy of 88 percent (5). Accuracy was higher in white and Hispanic children than in Asian and African children; however, it remained at 82 percent or higher for all groups.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. CT Haring et al., Oncotarget, 12, 1214 (2021). PMID: 34194620.
  2. KA Connolly et al., Science Immuno, [Online ahead of print] (2021).
  3. H Kashiwagi et al., B Chem Soc Jpn, [Online ahead of print] (2021).
  4. WA Werbel et al., Clin Infect Dis, [Online ahead of print] (2021). PMID: 34453519.
  5. AR Porras et al., Lancet Digit Health, [Online ahead of print] (2021). PMID: 34481768.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.